A Fixed-Duration, Measurable Residual Disease–Guided Approach in Chronic Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Fixed-Duration, Measurable Residual Disease-Guided Approach in CLL: Follow-Up Data From the Phase 2 ICLL-07 FILO Trial
Blood 2020 Nov 09;[EPub Ahead of Print], AS Michallet, R Letestu, M Le Garff-Tavernier, CM Aanei, M Ticchioni, MS Dilhuydy, F Subtil, V Rouille, B Mahe, K Laribi, B Villemagne, GA Salles, O Tournilhac, AJ Delmer, C Portois, B Pegourie, V Leblond, C Tomowiak, S De Guibert, F Orsini Piocelle, A Banos, P Carassou, G Cartron, LM Fornecker, L Ysebaert, C Dartigeas, M Truchan-Graczyk, JP Vilque, T Aurran, F Cymbalista, S Lepretre, V Levy, F Nguyen-Khac, P FeugierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.